Neurocrine Biosciences (NBIX) said Friday it appointed Sanjay Keswani as chief medical officer, effective June 2.
He will succeed Eiry Roberts, who will transition to the role of a strategic advisor, the company said. Keswani was most recently the president and CEO of ImmunoBrain.
Price: 95.40, Change: -7.49, Percent Change: -7.28
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。